Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JYHZ2300305	二甲双胍恩格列净片（III）	empagliflozin;metformin hydrochloride	Tablet	Chemical Drugs	License Renew	2023-07-15	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG	view
JYHZ2300306	二甲双胍恩格列净片（III）	empagliflozin;metformin hydrochloride	Tablet	Chemical Drugs	License Renew	2023-07-15	Boehringer Ingelheim (China) Investment Co Ltd;Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG	view
CYHS2301800	二甲双胍恩格列净片（III）	empagliflozin;metformin hydrochloride	Tablet	Chemical Drugs(4)	Generic Drug	2023-07-04	Hangzhou Zhuyangxin Pharmaceutical Co Ltd	view
JYHB2200425	二甲双胍恩格列净片（III）	empagliflozin;metformin hydrochloride	Tablet	Chemical Drugs	Supplementary Application	2022-08-08	Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma Gmbh & Co KG	view